Hikma Pharmaceuticals PLC (LON: HIK)
London
· Delayed Price · Currency is GBP · Price in GBp 2,110.00
+26.00 (1.25%)
Jan 21, 2025, 4:58 PM BST
Hikma Pharmaceuticals Market Cap
Hikma Pharmaceuticals has a market cap or net worth of 4.68 billion as of January 21, 2025. Its market cap has increased by 11.71% in one year.
Market Cap
4.68B
Enterprise Value
5.49B
Revenue
2.39B
Ranking
n/a
PE Ratio
20.96
Stock Price
2,110.00
Market Cap Chart
Since November 2, 2005, Hikma Pharmaceuticals's market cap has increased from 469.64M to 4.68B, an increase of 896.27%. That is a compound annual growth rate of 12.70%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| HUTCHMED (China) | 1.99B |
| Oxford Nanopore Technologies | 1.42B |
| Indivior | 1.23B |